Literature DB >> 14735465

Bcl-xL inhibits p53- but not apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line.

Remilio A L Schoop1, Klaas Kooistra, Robert J Baatenburg De Jong, Mathieu H M Noteborn.   

Abstract

Nonfunctional p53 and especially upregulation of Bcl-x(L) result in advanced disease and poor prognosis of patients suffering head and neck squamous cell carcinoma (HNSCC). Aberrancies of Bcl-x(L) and/or p53 in HNSCC lead to inability of anticancer drugs to induce apoptosis. Bcl-x(L) and/or mutated p53 inhibit the apoptotic process by preventing the mitochondrial release of cytochrome c and/or activation of execution caspases. Here, we report that expression of the avian virus-derived apoptin protein resulted in induction of apoptosis in the HNSCC-derived cell line UMSSC-14B despite the presence of nonfunctional p53. Apoptin activated the execution caspase 3 and induced the release of mitochondrial cytochrome c. Upregulation of Bcl-x(L) in UMSCC-14B cells did not interfere with the apoptin-induced apoptosis, whereas it clearly negatively affected the p53-induced one. Bcl-x(L) significantly decreased the p53-induced cytochrome c release, but not the apoptin-triggered one. Our data demonstrate that apoptin induces apoptosis independent of Bcl-x(L) and p53 and may constitute a potential therapeutic agent for treatment of HNSCC. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735465     DOI: 10.1002/ijc.11675

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Mechanisms of Apoptin-induced cell death.

Authors:  Suna Zhou; Mingxin Zhang; Jia Zhang; Hui Shen; Ermek Tangsakar; Jiansheng Wang
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

2.  TAT-Apoptin induces apoptosis in the human bladder cancer EJ cell line and regulates Bax, Bcl-2, caspase-3 and survivin expression.

Authors:  Jun Li; Haifeng Wang; Zhen Ma; Wenxing Fan; Yanfeng Li; Bingbing Han; Zhijia Zhang; Jiansong Wang
Journal:  Exp Ther Med       Date:  2012-03-21       Impact factor: 2.447

3.  Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent.

Authors:  M Burek; S Maddika; C J Burek; P T Daniel; K Schulze-Osthoff; M Los
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

4.  Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

Authors:  Jack Zhang; George Tsaprailis; G Tim Bowden
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

5.  Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells.

Authors:  Su-Xia Han; Jin-Lu Ma; Yi Lv; Chen Huang; Hai-Hua Liang; Kang-Min Duan
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

6.  AdHu5-apoptin induces G2/M arrest and apoptosis in p53-mutated human gastric cancer SGC-7901 cells.

Authors:  Qianqian Li; Hongbin Zhang; Cui Tan; Weiyan Peng; Guosheng Ren; Bei Jia; Ying He; Pilong Wang; Xiangyang Zhou; Tingxiu Xiang
Journal:  Tumour Biol       Date:  2013-06-28

Review 7.  Viral genes as oncolytic agents for cancer therapy.

Authors:  Shishir Kumar Gupta; Ravi Kumar Gandham; A P Sahoo; A K Tiwari
Journal:  Cell Mol Life Sci       Date:  2014-11-19       Impact factor: 9.207

8.  A mouse model for oral squamous cell carcinoma.

Authors:  Remilio A L Schoop; Mathieu H M Noteborn; Robert J Baatenburg de Jong
Journal:  J Mol Histol       Date:  2009-08-14       Impact factor: 2.611

9.  Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.

Authors:  Xiao Li; Yan Liu; Zhongmei Wen; Chang Li; Huijun Lu; Mingyao Tian; Kuoshi Jin; Lili Sun; Pegn Gao; Encheng Yang; Xiaohong Xu; Shifu Kan; Zhuoyue Wang; Yuhang Wang; Ningyi Jin
Journal:  Mol Cancer       Date:  2010-01-20       Impact factor: 27.401

10.  Therapeutic anti-tumor effect of exogenous apoptin driven by human survivin gene promoter in a lentiviral construct.

Authors:  Feng Ye; Bo Zhong; Guorong Dan; Fan Jiang; Yan Sai; Jiqing Zhao; Huiqin Sun; Zhongmin Zou
Journal:  Arch Med Sci       Date:  2013-05-28       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.